Israeli 3D bioprinting company raises 5M euros

By staff writers

September 26, 2019 -- Israeli 3D bioprinting company CollPlant Biotechnologies has raised 5 million euros to fund its efforts using 3D printing to create synthetic tissues and organs based on medical images, according to a report on

The company has been using bioinks such as recombinant human collagen to manufacture synthetic lungs for patients requiring transplantation. Most recently, CollPlant has developed a prototype 3D-bioprinted implant to support the regeneration of breast tissue.

Ami Sagi purchased the largest share of the convertible loans at 1.8 million euros with the remainder of the funds coming from various U.S. investors, the report noted.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking